Department of Pathophysiology, “Laiko” Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
Volume 29, Issue 3, September 2018
Sign in to download the Issue in PDF format.
850515446
Mediterr J Rheumatol 2018;29(3):173-7
Article Links
Extensive phenotyping of vascular damage in non-infectious primary vasculitides with the use of non-invasive vascular biomarkers: prevalence, pathogenesis and response to treatment
Abstract
Non-Infectious Primary systemic vasculitides (NIPSV) encompass a subset of autoimmune diseases, characterized mainly by intramural inflammation of the vascular wall. The increased mortality that some exhibit is partially attributed to vascular complications involving both micro- and macro- circulation. Beyond the disease specific pathways of vascular damage, emerging evidence suggest that the classical pathways of arterial damage, namely, atheromatosis, inappropriate arterial remodeling and arteriosclerosis are accelerated in several NIPSV; thus participating in the development of vascular complications in NIPSV patients. The aim of the current research protocol is to optimize the understanding of vascular pathology in NIPSV and to identify useful, easy to measure, non-invasive vascular tools for the diagnosis and follow-up of NIPSV patients. Moreover, the study aims to generate hypothesis regarding the molecular basis of the association of inflammation with classical vascular pathology.https://doi.org/10.31138/mjr.29.3.173
Keywords: Non-infectious primary vasculitides, vascular damage, arterial stiffness, atheromatosis, arterial remodeling, arterial hypertrophy, arteriosclerosis, cardiovascular risk factors, inflammation, anti-inflammatory treatment